235 related articles for article (PubMed ID: 31855686)
1. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
[TBL] [Abstract][Full Text] [Related]
2. Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.
Li C; Hu J; Li W; Song G; Shen J
Biomater Sci; 2016 Dec; 5(1):77-88. PubMed ID: 27822577
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of Rhenium Disulfide/Mesoporous Silica Core-Shell Nanoparticles for a pH-Responsive Drug Release and Combined Chemo-Photothermal Therapy.
Na H; Carrier J; Oyon S; Lai CY
ACS Appl Bio Mater; 2024 May; 7(5):3337-3345. PubMed ID: 38700956
[TBL] [Abstract][Full Text] [Related]
5. The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development.
Shen J; Wang R; Wang Q; Zhang M; Liu C; Tao Z; Su G
Aging (Albany NY); 2020 Dec; 13(1):411-423. PubMed ID: 33290262
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional NaYF4:Yb, Er@mSiO2@Fe3O4-PEG nanoparticles for UCL/MR bioimaging and magnetically targeted drug delivery.
Liu B; Li C; Ma P; Chen Y; Zhang Y; Hou Z; Huang S; Lin J
Nanoscale; 2015 Feb; 7(5):1839-48. PubMed ID: 25521795
[TBL] [Abstract][Full Text] [Related]
7. A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.
Liu S; Li W; Gai S; Yang G; Zhong C; Dai Y; He F; Yang P; Suh YD
Biomater Sci; 2019 Feb; 7(3):951-962. PubMed ID: 30534762
[TBL] [Abstract][Full Text] [Related]
8. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
[TBL] [Abstract][Full Text] [Related]
9. Amine-functionalized, porous silica-coated NaYF
Reddy KL; Sharma PK; Singh A; Kumar A; Shankar KR; Singh Y; Garg N; Krishnan V
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():86-95. PubMed ID: 30606601
[TBL] [Abstract][Full Text] [Related]
10. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
11. A facile fabrication of upconversion luminescent and mesoporous core-shell structured β-NaYF
Li C; Hou Z; Dai Y; Yang D; Cheng Z; Ma P; Lin J
Biomater Sci; 2013 Feb; 1(2):213-223. PubMed ID: 32481801
[TBL] [Abstract][Full Text] [Related]
12. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy.
Shen J; Song G; An M; Li X; Wu N; Ruan K; Hu J; Hu R
Biomaterials; 2014 Jan; 35(1):316-26. PubMed ID: 24125776
[TBL] [Abstract][Full Text] [Related]
13. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
14. Photo-induced reactions for disassembling of coloaded photosensitizer and drug molecules from upconversion-mesoporous silica nanoparticles: An effective synergistic cancer therapy.
Rafique R; Gul AR; Lee IG; Baek SH; Kailasa SK; Iqbal N; Cho EJ; Lee M; Park TJ
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110545. PubMed ID: 32204054
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared control and real-time detection of osteogenic differentiation in mesenchymal stem cells by multifunctional upconversion nanoparticles.
Wang K; Wu Q; Wang X; Liang G; Yang A; Li J
Nanoscale; 2020 May; 12(18):10106-10116. PubMed ID: 32350492
[TBL] [Abstract][Full Text] [Related]
16. Triple function nanocomposites of porous silica-CoFe
Fan H; Xing X; Yang Y; Li B; Wang C; Qiu D
Dalton Trans; 2017 Nov; 46(43):14831-14838. PubMed ID: 29043319
[TBL] [Abstract][Full Text] [Related]
17. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
Ran Z; Sun Y; Chang B; Ren Q; Yang W
J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
[TBL] [Abstract][Full Text] [Related]
19. Degradable magnetic-response photoacoustic/up-conversion luminescence imaging-guided photodynamic/photothermal antitumor therapy.
Lv R; Jiang X; Yang F; Wang Y; Feng M; Liu J; Tian J
Biomater Sci; 2019 Nov; 7(11):4558-4567. PubMed ID: 31532406
[TBL] [Abstract][Full Text] [Related]
20. Anisotropic growth-induced synthesis of dual-compartment Janus mesoporous silica nanoparticles for bimodal triggered drugs delivery.
Li X; Zhou L; Wei Y; El-Toni AM; Zhang F; Zhao D
J Am Chem Soc; 2014 Oct; 136(42):15086-92. PubMed ID: 25251874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
